Protease inhibitors targeting the main protease and papain-like protease of coronaviruses-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Protease inhibitors targeting the main protease and papain-like protease of coronaviruses

Published:2020-12-12 Issue:4 Volume:31 Page:309-324
ISSN:1354-3776
Container-title:Expert Opinion on Therapeutic Patents
language:en
Short-container-title:Expert Opinion on Therapeutic Patents

Author:

Capasso Clemente¹^ORCID,Nocentini Alessio²^ORCID,Supuran Claudiu T²^ORCID

Affiliation:

1. Department of Biology, Agriculture and Food Sciences, CNR, Institute of Biosciences and Bioresources, Napoli, Italy

2. Dipartimento Neurofarba, Sezione di Scienze Farmaceutiche e Nutraceutiche, Università Degli Studi di Firenze, Sesto Fiorentino (Florence), Italy

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543776.2021.1857726

Reference109 articles.

1. SARS-CoV-2 and COVID-19: From the Bench to the Bedside

2. COVID-19 outbreak: Migration, effects on society, global environment and prevention

3. Corrigendum to “The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China” [J. Autoimmun. 109C (2020) 102434]

4. A deadly spillover: SARS-CoV-2 outbreak

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Discovery of Peptidomimetics for the Treatment of Coronavirus (COVID-19), Human Coronavirus, and Enteroviruses;Current Medicinal Chemistry;2024-03

2. Development of Fluorescence-Based Assays for Key Viral Proteins in the SARS-CoV-2 Infection Process and Lifecycle;International Journal of Molecular Sciences;2024-03-01

3. Therapeutic cysteine protease inhibitors: a patent review (2018–present);Expert Opinion on Therapeutic Patents;2024-02

4. Classification, replication, and transcription of Nidovirales;Frontiers in Microbiology;2024-01-24

5. Leveraging SARS-CoV-2 Main Protease (Mpro) for COVID-19 Mitigation with Selenium-Based Inhibitors;International Journal of Molecular Sciences;2024-01-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3